The Double-Edged Sword of Immunotherapy-Durvalumab-Induced Polyendocrinopathy-Case Report. - Błażowska O; Stróżna K; Dancewicz H; Zygmunciak P; Zgliczyński W; Mrozikiewicz-Rakowska B (Journal of clinical medicine, 2024)